Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Comment by GekkoInvestor19on Jun 04, 2020 2:37pm
98 Views
Post# 31112931

RE:RE:RE:RE:RE:RE:This is the month!

RE:RE:RE:RE:RE:RE:This is the month!

Couldn't agree more! I'm not a health care professional and will not pretend to know the intricacies of acquiring patients for clinical trials, or the liabilities and hurdles that it comes with... However, if you already have an FDA approved product, and you're simply repurposing it, it should not take 3 months to complete a clinical trial with 10 patients. 

You could likely find Grad Students that could access 10 participants for a clinical trial as part of a degree practicum, so why this is so challenging is beyond me. 

I do believe that Guy needs to keep his investors properly informed, regardless of what little information he may have to provide. If we're investing thousands of dollars into a company, one would imagine that we should be entitled to information regarding the status of the company. 

If I had 6 million dollars at my disposal, and was head of a Biologics company that was producing a Stem Cell Therapy to treat a Global Pandemic in 2020, I would invest in a marketing team to properly promote and inform prospective investors of my product, so that when I have positive results to publish, people are already familiar with my product and company. 

But who am I...

<< Previous
Bullboard Posts
Next >>